Reference number : 236-2018-2019-Q3-00432, amendment number : , agreement type : G, recipient legal name : Kobelev, Maxim, recipient country : CA, recipient province : BC, recipient city : Vancouver, recipient postal code : V6T 1Z1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 17500.0, agreement start date : 2018-05-01, agreement end date : 2019-04-30, description english : Rationale targeting ASCL1 in highly aggressive Neuroendocrine prostate cancer, description french : Rationale targeting ASCL1 in highly aggressive Neuroendocrine prostate cancer, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada